Drug shortage slows clinical trials

By Heidi Ledford of Nature magazine Potential cancer treatments are loitering in the wings as clinical trials are delayed by widespread shortages of common chemotherapy drugs. The I-SPY 2 Breast Cancer Clinical Trial, for example, a high-profile experiment aiming to test the use of certain molecular markers to guide cancer treatment, was designed to allow researchers to adapt the study's protocol in response to early results. [More]

The rest is here:
Drug shortage slows clinical trials